News Archives

Deutsche Börse welcomes Rodos Biotarget to the Venture Network

Hannover, 24 August 2016. Rodos Biotarget GmbH is pleased about its membership in the Deutsche Börse Venture Network (DBVN). Access to the non-public network is based on a qualification process; several criteria must be met in order to join the network. The Venture Network is a platform designed to bring classified high-growth companies and international investors from the categories PE/VC, Family Office, High Net Worth Individuals (HNWI) and Public Equity together and create an environment for effective growth financing.

Posted in Press